LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 42,304 Value ($000) $60 Avg Close $1.38 Range $1.24 - $1.57
Q4 2022
Shares 10,400 Value ($000) $12 Avg Close $1.26 Range $1.02 - $1.51